Doping control of estra‐4,9‐diene‐3,17‐dione in horses
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Helen S M Ho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Anabolic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Estra‐4,9‐diene‐3,17‐dione (dienedione) is an anabolic‐androgenic steroid (AAS) available on the market as a dietary supplement for bodybuilding. It is prohibited in both human and equine sports due to its potential performance‐enhancing effect. With the rare presence of the 4,9‐diene configuration in endogenous steroids, dienedione has been considered as a synthetic AAS. Nevertheless, the reoccurring detection of dienedione in entire male horse urine samples led to the investigation of its possible endogenous nature in horses, and its endogenous nature in entire male horses has been recently confirmed and reported by the authors' laboratory. While dienedione is not detected in castrated horses (geldings), it is essential to study its elimination and identify its metabolites for its effective control. To study the elimination and biotransformation of dienedione, administration experiments were performed by giving three castrated horses (geldings) each single oral dose of 1500 mg of dienedione powder for seven consecutive days. The postulated in vivo metabolites included 17‐hydroxyestra‐4,9‐dien‐3‐one (M1a and M1b), hydroxylated dienedione (M2a, M2b, M3a, M3b, M4, M5) and hydroxylated M1 (M6a, M6b, M7a, M7b, M8a and M8b), formed from hydroxylation and reduction of dienedione. To control the misuse of dienedione in geldings, M3a and M3b are the potential targets that gave the longest detection time, which could be detected for up to 2–5 days in urine and 0.4–4 days in plasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China.
- Department of Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
- Department of Equestrian Affairs, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
ORCID-Profile: Helen S M Ho
Zitieren
APA
Ho, H. S. M., Farrington, A. F., Bond, A. J., Ho, E. N. M., & Wong, W. T. (2025). Doping control of estra‐4,9‐diene‐3,17‐dione in horses. Drug Testing and Analysis. https://doi.org/10.1002/dta.3756
Vancouver
Ho HSM, Farrington AF, Bond AJ, Ho ENM, Wong WT. Doping control of estra‐4,9‐diene‐3,17‐dione in horses. Drug Testing and Analysis. 2025. doi:10.1002/dta.3756
BibTeX
@article{Ho2025,
author = {Ho, Helen S M and Farrington, Adrian F and Bond, Amanda J and Ho, Emmie N M and Wong, Wing-Tak},
title = {Doping control of estra‐4,9‐diene‐3,17‐dione in horses},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3756}
}
EUVIMED